A Phase III Trial of Modified FOLFOX6 Versus CAPOX, With Bevacizumab (NSC-704865) or Placebo, as First-Line Therapy in Patients With Previously Untreated Advanced Colorectal Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab; Capecitabine; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 25 Jan 2013 Biomarkers information updated
- 24 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 25 Oct 2007 Status changed from in progress to completed.